Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000121189 | SCV000522524 | benign | not specified | 2016-09-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000861382 | SCV001001682 | benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000121189 | SCV001474904 | benign | not specified | 2020-07-27 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000121189 | SCV002065004 | benign | not specified | 2017-09-29 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002326704 | SCV002600911 | likely benign | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs78772552 with MODY3. | |
Ambry Genetics | RCV002326704 | SCV002740517 | benign | Maturity onset diabetes mellitus in young | 2016-08-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003315518 | SCV004015766 | benign | Nonpapillary renal cell carcinoma | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030496 | SCV000053167 | not provided | Maturity-onset diabetes of the young type 3 | 2011-11-26 | no assertion provided | clinical testing | |
ITMI | RCV000121189 | SCV000085358 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |